BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37339334)

  • 21. Para This, Fibromin That: The Role of CDC73 in Parathyroid Tumors and Familial Tumor Syndromes.
    Ababneh E; Nosé V
    Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent hyperparathyroidism and a novel nonsense mutation in a patient with hyperparathyriodism-jaw tumor syndrome.
    Abdulla AG; O'Leary EM; Isorena JP; Diaz MF; Yeh MW
    Endocr Pract; 2013; 19(6):e134-7. PubMed ID: 23757631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
    Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
    Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
    Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.
    Bradley KJ; Hobbs MR; Buley ID; Carpten JD; Cavaco BM; Fares JE; Laidler P; Manek S; Robbins CM; Salti IS; Thompson NW; Jackson CE; Thakker RV
    J Intern Med; 2005 Jan; 257(1):18-26. PubMed ID: 15606373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A two-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report.
    Yang D; Zheng J; Tang F; He Q; Huang H; Zhou P
    Diagn Pathol; 2022 Sep; 17(1):71. PubMed ID: 36153594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.
    Grigorie D; Sucaliuc A; Ciuffi S; Franceschelli F; Marini F; Ioachim D; Terzea D; Brandi MLL
    Acta Endocrinol (Buchar); 2019; 15(3):398-403. PubMed ID: 32010362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
    Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
    Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
    Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
    Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.
    Sun W; Kuang XL; Liu YP; Tian LF; Yan XX; Xu W
    Sci Rep; 2017 Nov; 7(1):15638. PubMed ID: 29142233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
    Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
    Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
    Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
    Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
    Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype of CDC73 germline mutation determines risk of parathyroid cancer.
    Li Y; Zhang J; Adikaram PR; Welch J; Guan B; Weinstein LS; Chen H; Simonds WF
    Endocr Relat Cancer; 2020 Sep; 27(9):483-494. PubMed ID: 32590342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features.
    Redwin Dhas MP; Karthiga KS; Tatu JE; Eugenia SJ
    Ethiop J Health Sci; 2017 May; 27(3):309-313. PubMed ID: 29217931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature.
    Torresan F; Iacobone M
    Int J Endocrinol; 2019; 2019():1761030. PubMed ID: 31929790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.